Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects

dc.authorid0000-0003-0791-0165
dc.authorid0000-0001-7444-6193
dc.authorid0000-0003-0287-5639
dc.authorid0000-0002-9797-3591
dc.contributor.authorErsahin, Mehmet
dc.contributor.authorOzsavci, Derya
dc.contributor.authorSener, Azize
dc.contributor.authorOzakpinar, Ozlem Bingol
dc.contributor.authorToklu, Hale Zerrin
dc.contributor.authorAkakin, Dilek
dc.contributor.authorSener, Goksel
dc.date.accessioned2025-05-10T19:36:17Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: The aim was to investigate the putative anti-inflammatory and anti-apoptotic effect of obestatin in a rat model of subarachnoidal haemorrhage (SAH). Methods: To induce SAH, rats were injected with 0.3 mL blood into their cisterna magna. At 48 hours rats were decapitated after neurological examination. Blood-brain barrier (BBB) permeability, brain water content, oxidative stress markers and histological analysis were done in brain tissue. Results: The results showed that neurological examination scores were increased in the SAH group and, moreover, BBB permeability was impaired and oedema formed. SAH resulted in increased levels of plasma tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 levels and caspase-3 activity. Lipid peroxidation and protein oxidation levels and myeloperoxidase activity were all increased in the brain tissue, with concomitant decreases in antioxidant enzymes. On the other hand, SAH-induced neurological impairment and oxidative brain injury were ameliorated in the obestatin-treated group. Conclusion: The present study provides the first evidence that peripheral administration of obestatin exerts potent anti-inflammatory and neuroprotective effects in SAH-induced oxidative damage by maintaining a balance in oxidant-antioxidant status through the augmentation of endogenous antioxidants and the inhibition of pro-inflammatory mediators.
dc.identifier.doi10.3109/02699052.2013.804199
dc.identifier.endpage1189
dc.identifier.issn0269-9052
dc.identifier.issn1362-301X
dc.identifier.issue10
dc.identifier.pmid23895491
dc.identifier.scopus2-s2.0-84881443047
dc.identifier.scopusqualityQ2
dc.identifier.startpage1181
dc.identifier.urihttps://doi.org/10.3109/02699052.2013.804199
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9141
dc.identifier.volume27
dc.identifier.wosWOS:000323365200011
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofBrain Injury
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectApoptosis
dc.subjectobestatin
dc.subjectoxidative
dc.subjectstress
dc.subjectsubarachnoid haemorrhage
dc.titleObestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9141.pdf
Boyut:
1022.72 KB
Biçim:
Adobe Portable Document Format